| Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines FA Van Nimwegen, G Ntentas, SC Darby, M Schaapveld, M Hauptmann, ... Blood, The Journal of the American Society of Hematology 129 (16), 2257-2265, 2017 | 234 | 2017 |
| Clinical intensity modulated proton therapy for Hodgkin lymphoma: which patients benefit the most? G Ntentas, K Dedeckova, M Andrlik, MC Aznar, B George, J Kubeš, ... Practical radiation oncology 9 (3), 179-187, 2019 | 34 | 2019 |
| Predicted risks of cardiovascular disease following chemotherapy and radiotherapy in the UK NCRI RAPID trial of positron emission tomography–directed therapy for early-stage … DJ Cutter, J Ramroth, P Diez, A Buckle, G Ntentas, B Popova, ... Journal of Clinical Oncology 39 (32), 3591-3601, 2021 | 26 | 2021 |
| Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010–2020 FK Duane, A Kerr, Z Wang, SC Darby, G Ntentas, MC Aznar, CW Taylor Radiotherapy and Oncology 164, 261-267, 2021 | 13 | 2021 |
| Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction G Ntentas, SC Darby, MC Aznar, DC Hodgson, RM Howell, MV Maraldo, ... Radiotherapy and Oncology 153, 155-162, 2020 | 11 | 2020 |
| The role of motion management and position verification in lymphoma radiotherapy M Aznar, G Ntentas, M Enmark, S Flampouri, P Meidhal Petersen, ... The British Journal of Radiology 94 (1127), 20210618, 2021 | 10 | 2021 |
| Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: A PTCOG Lymphoma Subcommittee report and recommendations CG Patel, J Peterson, M Aznar, YD Tseng, S Lester, D Pafundi, ... Radiotherapy and Oncology 177, 21-32, 2022 | 8 | 2022 |
| Proton therapy in supradiaphragmatic lymphoma: predicting treatment-related mortality to help optimize patient selection G Ntentas, K Dedeckova, M Andrlik, MC Aznar, R Shakir, J Ramroth, ... International Journal of Radiation Oncology* Biology* Physics 112 (4), 913-925, 2022 | 7 | 2022 |
| Proton beam therapy for early breast cancer: a systematic review and meta-analysis of clinical outcomes F Holt, J Probert, SC Darby, JS Haviland, CE Coles, AM Kirby, Z Liu, ... International Journal of Radiation Oncology* Biology* Physics 117 (4), 869-882, 2023 | 5 | 2023 |
| Implementation of a comprehensive set of optimised CBCT protocols and validation through imaging quality and dose audit M Khan, N Sandhu, M Naeem, R Ealden, M Pearson, A Ali, I Honey, ... The British Journal of Radiology 95 (1139), 20220070, 2022 | 5 | 2022 |
| Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry DA Jones, P Candio, R Shakir, G Ntentas, J Ramroth, AM Gray, DJ Cutter Blood Advances 6 (3), 909-919, 2022 | 5 | 2022 |
| OC-0059: A radiation dose-response relationship for risk of heart failure in survivors of Hodgkin lymphoma BMP Aleman, FA Van Nimwegen, G Ntentas, SC Darby, M Schaapveld, ... Radiotherapy and Oncology 119, S25-S26, 2016 | 2 | 2016 |
| Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma OA Houlihan, G Ntentas, DJ Cutter, P Daly, C Gillham, O McArdle, ... Clinical and Translational Oncology 25 (5), 1368-1377, 2023 | 1 | 2023 |
| Association of radiation and procarbazine dose with risk of colorectal cancer among survivors of Hodgkin lymphoma YM Geurts, R Shakir, G Ntentas, S Roberti, MC Aznar, KM John, ... JAMA oncology 9 (4), 481-489, 2023 | 1 | 2023 |
| PO-1972 DIBH for mediastinal lymphoma: Implementation and evaluation of a 5-year service K Jones, A Webster, G Ntentas, J Brady, NG Mikhaeel Radiotherapy and Oncology 161, S1678-S1679, 2021 | 1 | 2021 |
| LYMPHOMA: ADVANCES IN IMAGING AND RADIOTHERAPY SPECIAL FEATURE: COMMENTARY Progress and pitfalls with the use of image-guided personalised approaches in lymphoma TM Illidge, E Phillips | 1 | 2021 |
| An excess mortality risk analysis of proton beam versus optimal photon radiotherapy for mediastinal Hodgkin lymphoma: who may benefit most? G Ntentas, K Dedeckova, M Andrilik, R Shakir, MC Aznar, J Ramroth, ... International Journal of Radiation Oncology, Biology, Physics 108 (3), S140-S141, 2020 | 1 | 2020 |
| Paving the way for modality choice of the future: challenges and expectations of the first simultaneous whole-body PET-MRI molecular imaging in the UK. M Masoomi, G Ntentas, L Foulsham Pakistan Journal of Nuclear Medicine 3 (1), 2013 | 1 | 2013 |
| TEMPORARY REMOVAL: Estimated doses to the heart, lungs and oesophagus and risks from typical UK radiotherapy for early breast cancer during 2015-2023 F Holt, A Ivanova, Z Wang, S Darby, F Duane, G Ntentas, S Oliveros, ... Clinical Oncology, 2024 | | 2024 |
| Hybrid PET-MR Imaging to Assess Acute Cardiovascular Changes in Response to Thoracic Radiotherapy and Chemotherapy in Cancer Patients G Ntentas, E Reyes, K Owczarczyk, R Crawley, I Reading, S Jeljeli, ... Journal of Cardiovascular Magnetic Resonance 26, 2024 | | 2024 |
